Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medite Cancer Diagnostics Inc (MDIT)
OTHER OTC:MDIT
Holding MDIT?
Track your performance easily
MDIT Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
MDIT FAQ
What was Medite Cancer Diagnostics Inc’s price range in the past 12 months?
Currently, no data Available
What is Medite Cancer Diagnostics Inc’s market cap?
Currently, no data Available
When is Medite Cancer Diagnostics Inc’s upcoming earnings report date?
Medite Cancer Diagnostics Inc’s upcoming earnings report date is Aug 14, 2017 which is 2662 days ago.
How were Medite Cancer Diagnostics Inc’s earnings last quarter?
Currently, no data Available
Is Medite Cancer Diagnostics Inc overvalued?
According to Wall Street analysts Medite Cancer Diagnostics Inc’s price is currently Overvalued.
Does Medite Cancer Diagnostics Inc pay dividends?
Medite Cancer Diagnostics Inc does not currently pay dividends.
What is Medite Cancer Diagnostics Inc’s EPS estimate?
Medite Cancer Diagnostics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medite Cancer Diagnostics Inc have?
Medite Cancer Diagnostics Inc has 86,196,700 shares outstanding.
What happened to Medite Cancer Diagnostics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medite Cancer Diagnostics Inc?
Currently, no hedge funds are holding shares in MDIT
---
Company Description
Medite Cancer Diagnostics Inc
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. The company was founded in December 1998 and is headquartered in Orlando, FL.
---
Advaxis
―
Inovio Pharmaceuticals
―
Northwest Biotherapeutics
―
Cellectar Biosciences
―
---